Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
J Immunol ; 200(1): 196-208, 2018 01 01.
Article de Anglais | MEDLINE | ID: mdl-29158417

RÉSUMÉ

Reactive oxygen species (ROS) produced by NADPH phagocyte oxidase isoform (NOX2) are critical for the elimination of intracellular pathogens in many infections. Despite their importance, the role of ROS following infection with the eukaryotic pathogen Leishmania has not been fully elucidated. We addressed the role of ROS in C57BL/6 mice following intradermal infection with Leishmania amazonensis. Despite equivalent parasite loads compared with wild-type (WT) mice, mice deficient in ROS production by NOX2 due to the absence of the gp91 subunit (gp91phox-/-) had significantly more severe pathology in the later stages of infection. Pathology in gp91phox-/- mice was not associated with alterations in CD4+ T cell-mediated immunity but was preceded by enhanced neutrophil accumulation at the dermal infection site. Ex vivo analysis of infected versus uninfected neutrophils revealed a deficiency in infection-driven apoptosis in gp91phox-/- mice versus WT mice. gp91phox-/- mice presented with higher percentages of healthy or necrotic neutrophils but lower percentages of apoptotic neutrophils at early and chronic time points. In vitro infection of gp91phox-/- versus WT neutrophils also revealed reduced apoptosis and CD95 expression but increased necrosis in infected cells at 10 h postinfection. Provision of exogenous ROS in the form of H2O2 reversed the necrotic phenotype and restored CD95 expression on infected gp91phox-/- neutrophils. Although ROS production is typically viewed as a proinflammatory event, our observations identify the importance of ROS in mediating appropriate neutrophil apoptosis and the importance of apoptosis in inflammation and pathology during chronic infection.


Sujet(s)
Inflammation/immunologie , Leishmania/immunologie , Leishmaniose/immunologie , NADPH Oxidase 2/métabolisme , Granulocytes neutrophiles/immunologie , Animaux , Apoptose , Mouvement cellulaire , Cellules cultivées , Femelle , Mâle , Souris , Souris de lignée C57BL , Souris knockout , NADPH Oxidase 2/génétique , Charge parasitaire , Espèces réactives de l'oxygène/métabolisme , Antigènes CD95/métabolisme
2.
PLoS Pathog ; 13(6): e1006479, 2017 Jun.
Article de Anglais | MEDLINE | ID: mdl-28666021

RÉSUMÉ

Inflammatory monocytes can be manipulated by environmental cues to perform multiple functions. To define the role of monocytes during primary or secondary infection with an intra-phagosomal pathogen we employed Leishmania major-red fluorescent protein (RFP) parasites and multi-color flow cytometry to define and enumerate infected and uninfected inflammatory cells in the skin. During primary infection, infected monocytes had altered maturation and were the initial mononuclear host cell for parasite replication. In contrast, at a distal site of secondary infection in mice with a healed but persistent primary infection, this same population rapidly produced inducible nitric oxide synthase (iNOS) in an IFN-γ dependent manner and was critical for parasite killing. Maturation to a dendritic cell-like phenotype was not required for monocyte iNOS-production, and enhanced monocyte recruitment correlated with IFN-γ dependent cxcl10 expression. In contrast, neutrophils appeared to be a safe haven for parasites in both primary and secondary sites. Thus, inflammatory monocytes play divergent roles during primary versus secondary infection with an intra-phagosomal pathogen.


Sujet(s)
Co-infection/microbiologie , Leishmania major , Leishmaniose cutanée/immunologie , Monocytes/microbiologie , Phagosomes/métabolisme , Peau/microbiologie , Animaux , Antigènes Ly/immunologie , Co-infection/immunologie , Cellules dendritiques/métabolisme , Femelle , Inflammation/microbiologie , Leishmaniose cutanée/parasitologie , Souris transgéniques , Monocytes/métabolisme , Granulocytes neutrophiles/métabolisme , Nitric oxide synthase type II/métabolisme , Phagosomes/immunologie , Récepteurs CCR2/immunologie , Récepteurs à l'interleukine-8A/immunologie
3.
Eur J Nutr ; 51(8): 927-37, 2012 Dec.
Article de Anglais | MEDLINE | ID: mdl-22086299

RÉSUMÉ

PURPOSE: Extracts of the mushroom Agaricus blazei (A. blazei) have been described as possessing immunomodulatory and potentially cancer-protective activities. However, these effects of A. blazei as a functional food have not been fully investigated in vivo. METHODS: Using apolipoprotein E-deficient (ApoE(-/-)) mice, an experimental model of atherosclerosis, we evaluated the effects of 6 or 12 weeks of A. blazei supplementation on the activation of immune cells in the spleen and blood and on the development of atherosclerosis. RESULTS: Food intake, weight gain, blood lipid profile, and glycemia were similar between the groups. To evaluate leukocyte homing and activation, mice were injected with (99m)Tc-radiolabeled leukocytes, which showed enhanced leukocyte migration to the spleen and heart of A. blazei-supplemented animals. Analysis of the spleen showed higher levels of activation of neutrophils, NKT cells, and monocytes as well as increased production of TNF-α and IFN-γ. Circulating NKT cells and monocytes were also more activated in the supplemented group. Atherosclerotic lesion areas were larger in the aorta of supplemented mice and exhibited increased numbers of macrophages and neutrophils and a thinner fibrous cap. A. blazei-induced transcriptional upregulation of molecules linked to macrophage activation (CD36, TLR4), neutrophil chemotaxy (CXCL1), leukocyte adhesion (VCAM-1), and plaque vulnerability (MMP9) were seen after 12 weeks of supplementation. CONCLUSIONS: This is the first in vivo study showing that the immunostimulatory effect of A. blazei has proatherogenic repercussions. A. blazei enhances local and systemic inflammation, upregulating pro-inflammatory molecules, and enhancing leukocyte homing to atherosclerosis sites without affecting the lipoprotein profile.


Sujet(s)
Agaricus/composition chimique , Athérosclérose/physiopathologie , Compléments alimentaires , Facteurs immunologiques/pharmacologie , Inflammation/physiopathologie , Animaux , Aorte/effets des médicaments et des substances chimiques , Aorte/physiopathologie , Apolipoprotéines E/déficit , Athérosclérose/immunologie , Antigènes CD36/génétique , Antigènes CD36/métabolisme , Adhérence cellulaire , Chimiokine CXCL1/génétique , Chimiokine CXCL1/métabolisme , Modèles animaux de maladie humaine , Corps fructifères de champignon/composition chimique , Inflammation/immunologie , Interféron gamma/immunologie , Leucocytes/effets des médicaments et des substances chimiques , Leucocytes/métabolisme , Foie/effets des médicaments et des substances chimiques , Foie/métabolisme , Activation des macrophages/effets des médicaments et des substances chimiques , Matrix metalloproteinase 9/génétique , Matrix metalloproteinase 9/métabolisme , Souris , Souris knockout , Monocytes/immunologie , Cellules T tueuses naturelles/effets des médicaments et des substances chimiques , Cellules T tueuses naturelles/immunologie , Granulocytes neutrophiles/immunologie , Myeloperoxidase/génétique , Myeloperoxidase/métabolisme , ARN messager/génétique , ARN messager/métabolisme , Rate/immunologie , Rate/métabolisme , Rate/anatomopathologie , Récepteur de type Toll-4/génétique , Récepteur de type Toll-4/métabolisme , Facteur de nécrose tumorale alpha/immunologie , Régulation positive , Molécule-1 d'adhérence des cellules vasculaires/génétique , Molécule-1 d'adhérence des cellules vasculaires/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...